Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0232


Breast cancer advances in clinical cancer genome era: from conventional to integrative genome analysis.

George Zografos MD, PhD.

Affiliation: Head of the Breast Unit, Head of 1st Department of Propaedeutic Surgery, University of Athens, Greece.

Tel: +306932524836


Since there is no abstract available we provide the first paragraph.
Important advances have been made over the last two decades in translating robust conventional research into clinical practice. But it seems that chance for further substantial improvement in patients' oncological outcomes is now modest if we continue the same traditional strategy based single genes and proteins research. Moving from reductionist to network biology and from single gene sequencing to whole exome and whole genome sequencing and to integrative omics analysis we are now entering into the clinical cancer genome epoch.

(Citation: Gastric & Breast Cancer 2012; 11(3): 149-150)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 3 July 2012